corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 43 of 144 pages ‹ First  < 41 42 43 44 45 >  Last ›

HSL12392
Godlee F.
Doctors and the drug industry
BMJ 2008 Jan 5; 336:
http://www.bmj.com.proxy.library.adelaide.edu.au/cgi/content/full/336/7634/0

HSL12393
Bruzzi P.
Non-drug industry funded research.
BMJ 2008 Jan 5; 336:(7634):1-2
http://www.bmj.com.proxy.library.adelaide.edu.au/cgi/content/full/336/7634/1

HSL12394
Forgacs I, Loganayagam A.
Overprescribing proton pump inhibitors.
BMJ 2008 Jan 5; 336:(7634):2-3
http://www.bmj.com.proxy.library.adelaide.edu.au/cgi/content/full/336/7634/2

HSL12395
Mozley C.
People should be free to spend their money as they wish.
BMJ 2008 Jan 5; 336:(7634):7
http://www.bmj.com.proxy.library.adelaide.edu.au/cgi/content/full/336/7634/7-a

HSL12396
Connery TP.
Is it worth it?
BMJ 2008 Jan 5; 336:(7634):7
http://www.bmj.com.proxy.library.adelaide.edu.au/cgi/content/full/336/7634/7-b

HSL12492
Lenzer J, Brownlee S.
Doctor takes "march of shame" to atone for drug company payments.
BMJ 2008 Jan 5; 336:(7634):20-1
http://www.bmj.com/cgi/content/full/336/7634/20

HSL12493
Lenzer J.
Nigerian judge orders arrests of Pfizer officials.
BMJ 2008 Jan 5; 336:(7634):11
http://www.bmj.com/cgi/content/full/336/7634/11

HSL12524
Goldacre B.
The data belongs to the patients who gave it to you.
The Guardian 2008 Jan 5
http://www.badscience.net/?p=603

HSL12235
Irwin T.
Pharma Spends Much More On Marketing Than On R&D
Marketing Daily 2008 Jan 4
http://publications.mediapost.com/index.cfm?fuseaction=Articles.san&s=73653&Nid=37899&p=448587

HSL12258
Bansal P, McCormick GE.
Judge denies class in Fosamax cases against Merck
Reuters 2008 Jan 4
http://www.reuters.com/article/health-SP/idUSN0431373620080107

HSL12309
IMS Health to Cut 10 Percent of Staff, Take Charge
Therapeutics Daily 2008 Jan 4
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1669651&contentType=sentryarticle&channelID=33

HSL12323
Taylor L.
Indian state takes steps to curb drug prices
PharmaTimes 2008 Jan 4
http://www.pharmatimes.com/WorldNews/article.aspx?id=12548&src=EWorldNews

HSL12269
Guyatt GH, Mills EJ, Elbourne D.
In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter
PLoS Medicine 2008 Jan 3; 5:(1):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050004

HSL12279
Rubenstein S.
With Iowa Caucuses in Wings, Pharma CEOs Talk Politics
The Wall Street Journal 2008 Jan 3
http://blogs.wsj.com/health/2008/01/03/with-iowa-caucuses-in-wings-pharma-ceos-talk-politics/

HSL12296
Allen TJ.
Warning: Drug Ads Can Make You Sick
AlterNet 2008 Jan 3
http://www.alternet.org/healthwellness/72357

HSL12303
Drug Firms Spent Twice R&D Budget on Marketing
Therapeutics Daily 2008 Jan 3
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1665445&contentType=sentryarticle&channelID=33

HSL12304
New Approaches to Drug Development Will Drive Drug Company Success, According to Tufts Center for the Study of Drug Development
PharmaLive 2008 Jan 3
http://pharmalive.com/news/index.cfm?articleID=503418&categoryid=9&newsletter=1#

HSL12307
Public Citizen: Antibiotic Leads to Tendon Ruptures; FDA Ignores Risks
PharmaLive 2008 Jan 3
http://pharmalive.com/news/index.cfm?articleID=503650&categoryid=43

HSL12324
Taylor L.
Sri Lanka clamps down on drug multinationals
PharmaTimes 2008 Jan 3
http://www.pharmatimes.com/WorldNews/article.aspx?id=12544&src=EWorldNews

HSL12339
Drug makers spend more on marketing than research: study
CBC News 2008 Jan 3
http://www.cbc.ca/consumer/story/2008/01/03/drugs.html

HSL13505
Gagnon MA, Lexchin J.
The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.
PLoS Med. 2008 Jan 3; 5:(1):e1
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050001

HSL12273
Reinberg S.
Most Free Drug Samples Go to Wealthy and Insured: Study undercuts notion that they're given to help the poor, some experts say
US News 2008 Jan 2
http://health.usnews.com/usnews/health/healthday/080102/most-free-drug-samples-go-to-wealthy-and-insured.htm

HSL12274
Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU.
Characteristics of Recipients of Free Prescription Drug Samples: A Nationally Representative Analysis
American Journal of Public Health 2008 Jan 2;
http://www.ajph.org/cgi/content/abstract/AJPH.2007.114249v1

HSL12301
Drug companies spend nearly double on marketing compared with research: study
The Canadian Press 2008 Jan 2
http://canadianpress.google.com/article/ALeqM5gZnWB_b33DySVzhz2Pv82zF1cBxA

HSL12305
Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
PharmaLive 2008 Jan 2
http://pharmalive.com/news/index.cfm?articleID=503204&categoryid=9&newsletter=1

HSL12329
Mansell P.
Tougher scrutiny needed to weed out CV effects, says FDA advisor
PharmaTimes 2008 Jan 2
http://www.pharmatimes.com/clinicalnews/article.aspx?id=12536&src=EWorldNews

HSL12330
Mansell P.
No “Swiss solution” for trial registry, insists Interpharma
PharmaTimes 2008 Jan 2
http://www.pharmatimes.com/clinicalnews/article.aspx?id=12538&src=EWorldNews

HSL12333
Taylor L.
EU to increase industry role in patient info?
PharmaTimes 2008 Jan 2
http://www.pharmatimes.com/WorldNews/article.aspx?id=12529&src=EWorldNews

HSL12340
Sonnenschein C.
Book review of 'The estrogen elixir: A history of hormone replacement therapy in America' by Elizabeth Siegel Watkins
Philosophy, Ethics, and Humanities in Medicine 2008 Jan 2; 3:(1):
http://www.peh-med.com/content/3/1/1/abstract

HSL12236
Junk food ad ban comes into force in Britain
Agence France-Presse 2008 Jan 1
http://ca.news.yahoo.com/s/afp/080101/health/lifestyle_britain_health_food_media_1

HSL12240
Nimesulide
ISDB / PharMeD Trade News, Hyderabad 2008 Jan 1

HSL12379
Kirk SM.
Prescriber profiling.
Ann Intern Med 2008 Jan 1; 148:(1):82
http://www.annals.org/cgi/content/full/148/1/82

HSL12380
Fugh-Berman A.
Prescriber profiling.
Ann Intern Med 2008 Jan 1; 148:(1):82
http://www.annals.org/cgi/content/full/148/1/82-a

HSL12381
Tsai AC.
Prescriber profiling.
Ann Intern Med 2008 Jan 1; 148:(1):81
http://www.annals.org/cgi/content/full/148/1/81

HSL12382
Pratt SE.
Prescriber profiling.
Ann Intern Med 2008 Jan 1; 148:(1):81-2
http://www.ncbi.nlm.nih.gov/pubmed/18166762

HSL12651
Journalism Award for Excellence in Women's Health Reporting
CNW Group 2008 Jan 1
http://www.newswire.ca/en/releases/archive/February2008/01/c6248.html

HSL12720
Hosansky T.
Bias in the Hot Seat
MeetingsNet 2008 Jan 1
http://meetingsnet.com/cmepharma/cme/education_pharmaceutical_industry_marketing_012808/

HSL12806
Kovaleski D.
No Pharma Funding
MeetingsNet 2008 Jan 1
http://meetingsnet.com/cmepharma/cme/no_pharma_funding_012808/index.html

HSL12088
Jones SC, Hall D, Munro G.
How effective is the revised regulatory code for alcohol advertising in Australia?
Drug Alcohol Rev 2008 Jan; 27:(1):29-38
http://www.informaworld.com/smpp/content?content=10.1080/09595230701499175

HSL12300
Olfson M, Marcus SC, Druss BG
Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample
Arch Gen Psychiatry 2008 Jan; 65:(1):94-101
http://archpsyc.ama-assn.org/cgi/content/abstract/65/1/94

HSL12318
The Right to Communicate
Adbusters 2008 Jan
http://www.adbusters.org

HSL12409
Fagin D.
Second Thoughts About Fluoride
Scientific American 2008 Jan
http://www.sciam.com/article.cfm?id=second-thoughts-on-fluoride

HSL12443
Rottlaender D, Hoppe UC.
[Risks of non-prescription medication, Clobutinol cough syrup as a recent example].
Dtsch Med Wochenschr 2008 Jan; 133:(4):144-6
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1017490

HSL12491
Senior K.
Pharmaceutical downsizing and oncology drug development.
Lancet Oncol 2008 Jan; 9:(1):11
http://www.ncbi.nlm.nih.gov/pubmed/18183658

HSL12588
Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR.
Race, Medical Researcher Distrust, Perceived Harm, and Willingness to Participate in Cardiovascular Prevention Trials.
Medicine (Baltimore) 2008 Jan; 87:(1):1-9
http://www.md-journal.com/pt/re/medicine/abstract.00005792-200801000-00001.htm;jsessionid=HchLG5ntJ14TLymTXC12jQThZdQqnbQNMjZN6ySQgK0cRnb5rvVP!101667287!181195629!8091!-1

HSL12598
Breckenridge A.
Post-marketing strategies for medicines.
Clin Pharmacol Ther 2008 Jan; 83:(1):24-5
http://www.nature.com/clpt/journal/v83/n1/abs/6100427a.html;jsessionid=B987F23C228744920AFB5DA429BF7CFD

HSL12665
Schneider PJ, Murphy JE, Pedersen CA.
Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients.
J Am Pharm Assoc (2003) 2008 Jan-Feb; 48:(1):58-63
http://www.ncbi.nlm.nih.gov/pubmed/18192132

HSL12667
Singh S, Trivedi AN.
Spontaneous reports as evidence of adverse drug reactions.
South Med J 2008 Jan; 101:(1):16
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/SMJ.0b013e31815d2b7f

HSL12703
Getz K, Faden L.
Racial disparities among clinical research investigators.
Am J Ther 2008 Jan-Feb; 15:(1):3-11
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00045391-200801000-00003

HSL12707
Freidin B, Timmermans S.
Complementary and alternative medicine for children's asthma: satisfaction, care provider responsiveness, and networks of care.
Qual Health Res 2008 Jan; 18:(1):43-55
http://qhr.sagepub.com/cgi/reprint/18/1/43

HSL12711
UnmotivatedAnonymous
PHARMA TV AD - Strivor
: YouTube 2008 Jan
http://www.youtube.com/user/UnmotivatedAnonymous

HSL12748
Howland RH.
How are drugs approved? Part 1: the evolution of the Food and Drug Administration
J Psychosoc Nurs Ment Health Serv 2008 Jan; 46:(1):15-9
http://www.ncbi.nlm.nih.gov/pubmed/18251347

HSL12749
McLay R, Klinski A.
Changes in prescription habits with the introduction of generic fluoxetine.
Mil Med 2008 Jan; 173:(1):100-4
http://www.ncbi.nlm.nih.gov/pubmed/18251340

HSL12751
Tobin L, de Almedia Neto AC, Wutzke S, Patterson C.
Influences on the prescribing of new drugs.
Aust Fam Physician 2008 Jan-Feb; 37:(1-2):78-81
http://www.ncbi.nlm.nih.gov/pubmed/18239759

HSL12788
Weinstein J.
Bias-free health care.
Can Fam Physician 2008 Jan; 54:(1):27
http://www.cfp.ca/cgi/pmidlookup?view=long&pmid=18208947

HSL12790
Sim I.
Trial registration for public trust: making the case for medical devices.
J Gen Intern Med 2008 Jan; 23:
http://www.springerlink.com/content/t07wuu73t920gl03/

HSL12871
Sanfélix J, Palop V, Pereiró I, Rubio E, Gosalbes V, Martínez-Mir I.
Gender influence in the quantity of drugs used in primary care.
Gac Sanit 2008 Jan; 22:(1):11-19

HSL12878
De Almeida Neto AC, Chen TF.
When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making
Pharmacy World and Science. 2008 Jan; 30:(1):3-8
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2082656

HSL12910
Wemos Foundation
A Bitter Pill
Amsterdam: Wemos Foundation 2008 Jan
http://www.somo.nl/html/paginas/pdf/A_Bitter_Pill.pdf

HSL12921
Winkler AL, Finegold D.
Giving patients a say: how to work with patient advocacy groups.
Nat Biotechnol 2008 Jan; 26:(1):23-6
http://www.ncbi.nlm.nih.gov/pubmed/18251047?dopt=Abstract

HSL12924
Bohrer RA.
Reach-through claims for drug target patents: Rx for pharmaceutical policy.
Nat Biotechnol 2008 Jan; 26:(1):55-6
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-55.html;jsessionid=0F293AA2AD8FD1645C3D814D3C88C130

HSL12925
Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, Daar AS, Singer PA.
Chinese health biotech and the billion-patient market.
Nat Biotechnol 2008 Jan; 26:(1):37-53
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-37.html

HSL12926
.
The regulator disapproves.
Nat Biotechnol 2008 Jan; 26:(1):1
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-1.html

HSL12961
Al-Jazairi AS, Bhareth S, Eqtefan IS, Al-Suwayeh SA.
Brand and generic medications: Are they interchangeable?
Ann Saudi Med. 2008 Jan-Feb; 28:(1):33-41
http://www.ncbi.nlm.nih.gov/pubmed/18299655

HSL12969
Moran N.
Fractured European market undermines biosimilar launches.
Nat Biotechnol. 2008 Jan; 26:(1):5-6
http://www.nature.com/doifinder/10.1038/nbt0108-5

HSL13055
Puliyel JM, Madhavi Y.
Vaccines: Policy for public good or private profit?
Indian J Med Res 2008 Jan; 127:(1):1-3
www.icmr.nic.in/ijmr/2008/january/editorial1.pdf

HSL13256
Schetky DH.
Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Child Adolesc Psychiatr Clin N Am 2008 Jan; 17:(1):113-25,
http://linkinghub.elsevier.com/retrieve/pii/S1056-4993(07)00075-2

HSL13381
Outterson K, Kesselheim AS.
Market-based licensing for HPV vaccines in developing countries.
Health Aff (Millwood) 2008 Jan-Feb; 27:(1):130-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/130

HSL13385
Goldman DP, Jena AB, Philipson T, Sun E.
Drug licenses: a new model for pharmaceutical pricing.
Health Aff (Millwood) 2008 Jan-Feb; 27:(1):122-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/122

HSL13443
Hartley H, Coleman CL.
News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory.
Health (London) 2008 Jan; 12:(1):107-32
http://hea.sagepub.com/cgi/content/abstract/12/1/107

HSL13499
Caulin C.
[History of the evaluation of medicines aiming for marketing authorization].
J Fr Ophtalmol. 2008 Jan; 31:(1):71-4
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=370&CodeRevue4=JFO&Path=REVUE/JFO/2008/31/1/ARTICLE120281938714.xml&Locations=

HSL13785
Dens N, Eagle LC, De Pelsmacker P.
Attitudes and self-reported behavior of patients, doctors, and pharmacists in New Zealand and Belgium toward direct-to-consumer advertising of medication.
Health Commun 2008 Jan-Feb; 23:(1):45-61
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10410230701805190

HSL13802
Grosjean OV.
The resistible growth of health care costs.
Acta Chir Belg 2008 Jan-Feb; 108:(1):4-14
http://www.ncbi.nlm.nih.gov/pubmed/18411565

HSL13947
Mohapatra PR.
Interaction between medical practitioners & pharmaceutical industry.
Indian J Med Res. 2008 Jan; 127:(1):93
http://www.icmr.nic.in/ijmr/2008/january/0115.pdf

HSL13973
Boyd MA, Roth K, Ralls SA, Chambers DW.
Beginning the discussion of commercialism in dentistry.
J Calif Dent Assoc 2008 Jan; 36:(1):57-65
http://www.cda.org/page/Library/cda_member/pubs/journal/jour0108/boyd.pdf

HSL14649
The indifferent industry: Big Pharma, essential medicines and Africa’s sick
: Forum for African Investigative Reporters (FAIR) 2008 Jan
http://www.mo.be/en/article/indifferent-industry

HSL15229
Islam MS, Farah SS.
Characteristics and Reliability of Online References Cited in the Pharmaceutical Promotional Brochures of Bangladesh
eHealth International Journal 2008 Jan; 4:(1):1-5
http://www.ehealthinternational.org/vol4num1/Vol4Num1p01.pdf

HSL15260
Islam MS, Farah SS.
Drug promotional brochure as a source of drug information in Bangladesh: a critical analysis of the brochures for the authenticity of information.
Calicut Medical Journal 2008 Jan-Mar; 6:(1):e5
http://calicutmedicaljournal.info/2008/1/e5.pdf

HSL15261
Thomas V.
Drugs: prescription and promotion in third world countries
Calicut Medical Journal 2008 Jan-Mar; 6:(1):e1
http://calicutmedicaljournal.info/2008/1/e1.pdf

HSL16505
Huff-Rousselle M
Global pharmaceuticals: ethics, markets, practices [Book review]
The International Journal of Health Planning and Management 2008 Jan; 23:(1):79-82
http://www3.interscience.wiley.com/journal/117925549/abstract

HSL19337
Stossel TP.
Response to AMA's Council on Ethical and Judicial Affairs draft report on 'Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine'
Medscape J Med 2008 12; 10:(6):137
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491684/?tool=pubmed

HSL19338
Stossel TP.
A biopsy of financial conflicts of interest in medicine.
Surgery 2008; 143:(2):193-8
http://www.surgjournal.com/article/S0039-6060(07)00747-7/abstract

HSL19028
Herndon MB, Schwartz LM, Woloshin S, Anthony D, Gallagher P, Fowler FJ, Fisher E.
Older patients perceptions of 'unnecessary' tests and referrals: a national survey of Medicare beneficiaries.
J Gen Intern Med 2008; 23:(10):1547-54
http://www.springerlink.com/content/935q6u7727u36226/

HSL12276
Henderson J, Miller G, Pan Y, Britt H.
The effect of advertising in clinical software on general practitioners’ prescribing behaviour
The Medical Journal of Australia 2008; 188:(1):15-20
http://www.mja.com.au/public/issues/188_01_070108/hen10412_fm.html

HSL12277
Harvey K, Korczak VS, Marron LJ, Newgreen DB.
Commercialism, choice and consumer protection: regulation of complementary medicines in Australia
The Medical Journal of Australia 2008; 188:(1):21-25
http://www.mja.com.au/public/issues/188_01_070108/har10522_fm.html

HSL12278
Raftery JP.
Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand
The Medical Journal of Australia 2008; 188:(1):26-28
http://www.mja.com.au/public/issues/188_01_070108/raf10125_fm.html

HSL12319
Dach C.
The Media's New Aesthetic: Why TV is About to Have a Major Mood Swing.
Adbusters 2008
http://www.adbusters.org

HSL12375
Lin HY, Liao CC, Cheng SH, Wang PC, Hsueh YS.
Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a taiwanese medical setting.
Drugs Aging 2008; 25:(1):49-59
http://www.ncbi.nlm.nih.gov/pubmed/18184029?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL12444
Adler NE, Koschorreck J, Rechenberg B.
Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.
Water Sci Technol 2008; 57:(1):91-7
http://www.ncbi.nlm.nih.gov/pubmed/18192745

HSL12446
Montagne M.
Drugs on the internet. I: introduction and web sites on psychedelic drugs.
Subst Use Misuse. 2008; 43:(1):17-25
http://www.informaworld.com/smpp/content?content=10.1080/10826080701690698

HSL12447
Woodcock J, Woosley R.
The FDA critical path initiative and its influence on new drug development.
Annu Rev Med 2008; 59:1-12:
http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.59.090506.155819

HSL12511
Coombes ID, Stowasser DA, Coombes JA, Mitchell C.
Why do interns make prescribing errors? A qualitative study
MJA 2008; 18:(2):89-94
http://www.mja.com.au/public/issues/188_02_210108/coo10971_fm.html

HSL12512
Millar JA, Silla RC, Lee GE, Berwick A.
The national inpatient medication chart: critical audit of design and performance at a tertiary hospital
MJA 2008; 188:(2):95-99
http://www.mja.com.au/public/issues/188_02_210108/mil10878_fm.html

HSL12513
Hassali MAA, Stewart K, Kong DCM.
A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines
MJA 2008; 188:(2):123-4
http://www.mja.com.au/public/issues/188_02_210108/letters_210108_fm-4.html

HSL12534
Loewenberg S.
Drug company trials come under increasing scrutiny
The Lancet 2008; 371:(9608):191-2
http://www.thelancet.com/journals/lancet/article/PIIS0140673608601191/fulltext

HSL12704
Etwel FA, Rieder MJ, Bend JR, Koren G.
A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions.
Drug Saf 2008; 31:(2):169-180
http://www.ncbi.nlm.nih.gov/pubmed/18217792

HSL12705
Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.
Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users : A Cohort Study Using Pharmacy Dispensing Data in The Netherlands.
Drug Saf 2008; 31:(2):143-58
http://www.ncbi.nlm.nih.gov/pubmed/18217790

HSL12721
Morgan S, Cunningham C.
The Effect of Evidence-Based Drug Coverage Policies on Pharmaceutical R&D: A Case Study from British Columbia
Longwoods Publishing 2008;
http://www.longwoods.com/product.php?productid=19524&page=1

HSL12762
Donner-banzhoff N, Sönnichsen A.
Strategies for prescribing statins
BMJ 2008; 336:(7639):288
http://www.bmj.com/cgi/content/extract/336/7639/288?etoc

HSL12918
Kapsak WR, Schmidt D, Childs NM, Meunier J, White C.
Consumer perceptions of graded, graphic and text label presentations for qualified health claims.
Crit Rev Food Sci Nutr 2008; 48:(3):248-56
http://www.informaworld.com/smpp/content?content=10.1080/10408390701286058

Page 43 of 144 pages ‹ First  < 41 42 43 44 45 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963